| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1015083820 |
| P356 | DOI | 10.1038/491021A |
| P698 | PubMed publication ID | 23128204 |
| P5875 | ResearchGate publication ID | 232913135 |
| P2093 | author name string | Soo Bin Park | |
| P2860 | cites work | Hepatitis E epidemic, Uganda | Q24609019 |
| Safety and efficacy of a recombinant hepatitis E vaccine | Q34002701 | ||
| Epidemiology of hepatitis E in China | Q37353718 | ||
| Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial | Q45189946 | ||
| P433 | issue | 7422 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | vaccine | Q134808 |
| hepatitis E | Q326643 | ||
| P304 | page(s) | 21-22 | |
| P577 | publication date | 2012-11-01 | |
| P1433 | published in | Nature | Q180445 |
| P1476 | title | Hepatitis E vaccine debuts | |
| P478 | volume | 491 |
| Q38213327 | A systematic review of hepatitis E virus infection in children |
| Q33747037 | A systematic review of the epidemiology of hepatitis E virus in Africa |
| Q92458456 | Antiviral Candidates for Treating Hepatitis E Virus Infection |
| Q38172045 | Bioengineering virus-like particles as vaccines |
| Q38385396 | Broad spectrum assessment of the epitope fluctuation--Immunogenicity hypothesis. |
| Q47751923 | Characterization of a Cyclic Nucleotide‐Activated K+ Channel and its Lipid Environment by Using Solid‐State NMR Spectroscopy |
| Q38172960 | Chemokine receptor modeling: an interdisciplinary approach to drug design |
| Q33577945 | Commercializing diarrhea vaccines for travelers. |
| Q51097272 | Conformation and topology of diacylglycerol kinase in E.coli membranes revealed by solid-state NMR spectroscopy |
| Q26782030 | Current Knowledge on Hepatitis E |
| Q34147696 | Dynamic conformational switching in the chemokine ligand is essential for G-protein-coupled receptor activation |
| Q39678686 | Enhancing NMR Sensitivity of Natural-Abundance Low-γ Nuclei by Ultrafast Magic-Angle-Spinning Solid-State NMR Spectroscopy |
| Q90961669 | Expression and Preparation of a G-Protein-Coupled Cannabinoid Receptor CB2 for NMR Structural Studies |
| Q41951581 | Expression, Functional Characterization, and Solid-State NMR Investigation of the G Protein-Coupled GHS Receptor in Bilayer Membranes |
| Q30427675 | G-protein-coupled receptor structure, ligand binding and activation as studied by solid-state NMR spectroscopy |
| Q34581567 | Guided reconstitution of membrane protein fragments |
| Q39237214 | Hepatitis A to E: what's new? |
| Q92726290 | Hepatitis E virus infection among pregnant women in Africa: systematic review and meta-analysis |
| Q37375936 | Hepatitis E virus: Current epidemiology and vaccine |
| Q54254955 | Hepatitis E: Update on Prevention and Control. |
| Q38137898 | Hepatitis E: current status. |
| Q36255105 | Identification of LukPQ, a novel, equid-adapted leukocidin of Staphylococcus aureus |
| Q51734324 | Identification of an Arg-Leu-Arg tripeptide that contributes to the binding interface between the cytokine MIF and the chemokine receptor CXCR4. |
| Q47561286 | Immunity against hepatitis E virus infection: Implications for therapy and vaccine development |
| Q37694885 | Immunogenicity and safety of hepatitis E vaccine in healthy hepatitis B surface antigen positive adults |
| Q30360845 | Invited review: GPCR structural characterization: Using fragments as building blocks to determine a complete structure. |
| Q54997353 | Lipid bilayer environments control exchange kinetics of deep cavitand hosts and enhance disfavored guest conformations. |
| Q64108455 | Long-term Antibody Persistence After Hepatitis E Virus Infection and Vaccination in Dongtai, China |
| Q37534616 | Management of hepatitis E virus (HEV) zoonotic transmission: protection of rabbits against HEV challenge following immunization with HEV 239 vaccine |
| Q47391455 | Microsecond Timescale Protein Dynamics: a Combined Solid-State NMR Approach. |
| Q40443628 | Modular virus-like particles for sublingual vaccination against group A streptococcus. |
| Q38167942 | Nanoparticle vaccines |
| Q36392735 | Peptides derived from CXCL8 based on in silico analysis inhibit CXCL8 interactions with its receptor CXCR1. |
| Q57805488 | Perspectives of solution NMR spectroscopy for structural and functional studies of integral membrane proteins |
| Q41469857 | Positive selection in cathelicidin host defense peptides: adaptation to exogenous pathogens or endogenous receptors? |
| Q40507392 | Prophylactic Hepatitis E Vaccine |
| Q42147541 | Proton-Detected Solid-State NMR Spectroscopy of a Zinc Diffusion Facilitator Protein in Native Nanodiscs |
| Q57896466 | Protonendetektierte Festkörper-NMR-Spektroskopie an einem Zinktransporter-Membranprotein in nativen Nanoscheiben |
| Q38268414 | Risk factors for hepatitis E virus infection and disease. |
| Q38862301 | Role of Conserved Disulfide Bridges and Aromatic Residues in Extracellular Loop 2 of Chemokine Receptor CCR8 for Chemokine and Small Molecule Binding |
| Q91524746 | Safety and immunogenicity of hepatitis E vaccine in elderly people older than 65 years |
| Q34290684 | Safety of an Escherichia coli-expressed bivalent human papillomavirus (types 16 and 18) L1 virus-like particle vaccine: an open-label phase I clinical trial. |
| Q40949031 | Seroprevalence of hepatitis E in HIV infected patients in Greece. |
| Q41474094 | Site-specific solid-state NMR studies of "trigger factor" in complex with the large ribosomal subunit 50S. |
| Q27685471 | Solid-state NMR spectroscopy structure determination of a lipid-embedded heptahelical membrane protein |
| Q50882288 | Solid-state NMR structures of integral membrane proteins |
| Q38895025 | Structural complexes of the agonist, inverse agonist and antagonist bound C5a receptor: insights into pharmacology and signaling |
| Q42155167 | Structure of the transmembrane domain of human nicastrin-a component of γ-secretase |
| Q44267130 | Structure prediction of GPCRs using piecewise homologs and application to the human CCR5 chemokine receptor: validation through agonist and antagonist docking |
| Q27679913 | Structure-guided design affirms inhibitors of hepatitis C virus p7 as a viable class of antivirals targeting virion release |
| Q30377191 | The role of experimental and computational structural approaches in 7TM drug discovery. |
| Q24618653 | Trial Watch |
| Q30395265 | Vibrational resonance, allostery, and activation in rhodopsin-like G protein-coupled receptors |
| Q92683962 | Virus-like particle vaccines for poliovirus types 1, 2, and 3 with enhanced thermostability expressed in insect cells |
| Q38088523 | Virus-like particles: the future of microbial factories and cell-free systems as platforms for vaccine development |
| Q34981578 | Why we need many more G protein-coupled receptor structures |
| Q38093833 | X-ray structural information of GPCRs in drug design: what are the limitations and where do we go? |
Search more.